PLoS ONE
(Jan 2019)
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.
Markus Riegersperger,
Max Plischke,
Anita Jallitsch-Halper,
Corinna Steinhauser,
Manuela Födinger,
Wolfgang C Winkelmayer,
Daniela Dunkler,
Gere Sunder-Plassmann
Affiliations
Markus Riegersperger
Max Plischke
Anita Jallitsch-Halper
Corinna Steinhauser
Manuela Födinger
Wolfgang C Winkelmayer
Daniela Dunkler
Gere Sunder-Plassmann
DOI
https://doi.org/10.1371/journal.pone.0218709
Journal volume & issue
Vol. 14,
no. 7
p.
e0218709
Abstract
Read online
Trial registrationPEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.
WeChat QR code
Close